Pre-transplant host status determines the outcomes in non-malignant disorders

Documenti analoghi

• Pre-transplant host status determines the outcomes in non-malignant disorders
  di: Darshan Kataria, et al.
  Pubblicazione: (2024-01-01)
• Risk factors, complement blockade and timely ileostomy for intestinal transplant-associated thrombotic microangiopathy: Lessons learned from a tertiary pediatric hospital
  di: Sanaa Khan, et al.
  Pubblicazione: (2024-01-01)
• The role of graft T-cell size in patients receiving alemtuzumab serotherapy for non-malignant disorders: results of an institutional protocol
  di: Ambreen Pandrowala, et al.
  Pubblicazione: (2024-01-01)
• HLA-mismatched (9 by 10 match) donor HSCT as a feasible alternative for pediatric patients lacking a fully matched donor
  di: Mahafrin Goiporia, et al.
  Pubblicazione: (2025-01-01)
• Narsoplimab for severe transplant-associated thrombotic microangiopathy
  di: Ambreen Pandrowala, et al.
  Pubblicazione: (2023-03-01)